MedTrace Logo

A Study in Critically Ill Patients Investigating Tolerability and Efficacy of Low-volume Pharmaconutrition (Intestamin)

NCT01167075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2010-07-22

No results posted yet for this study

Summary

The aim of the study is to assess the efficacy and tolerability of the low-volume supplement. The investigators randomized critically ill patients to receive Intestamin plus Fresubin or Fresubin alone.

Conditions

  • Critical Illness
  • Adult
  • Sepsis
  • Systemic Inflammatory Response Syndrome

Interventions

DIETARY_SUPPLEMENT

Fresubin Original

DIETARY_SUPPLEMENT

Intestamin plus Fresubin Original

Sponsors & Collaborators

  • Fresenius Kabi

    collaborator INDUSTRY

  • Hannover Medical School

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01167075 on ClinicalTrials.gov